infertility
Conditions
Interventions
control group:western medicine
Sponsors
Affiliated Hospital of Chengdu University of TCM
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1) Second ART treatment cycle, previous IVF cycle = 35 years old, AMH >= 1.2ng/ml, AFC >= 5, the number of eggs obtained in the previous IVF 1~9; Or age < 35, AMH < 1.2ng/ml (groups 2 and 3 meeting the classification criteria of Poseidon population); (3) With INDICATIONS for IVF/ICSI, excluding contraindications; (4) The patient has no blastocyst or frozen embryo; (5) All patients were treated with antagonist regimen for drainage promotion; (6) Those who meet the standard of syndrome differentiation of kidney Yin deficiency, liver stagnation and blood stasis; (7) Knowing and voluntarily signing the informed consent. Note: only those who conform to the above 7 items can be included.
Exclusion criteria
Exclusion criteria: (1) Study on the Efficacy of Traditional Chinese medicine combined with multi-pathway intervention in patients with re-IVF-ET antagonist with Kidney Yin deficiency, Liver stagnation and blood stasis; (2) Patients with drug allergy or allergic constitution; (3) Patients with severe primary diseases such as cardiovascular, liver, kidney and hematopoietic system, or mental diseases; (4) Patients with acute infectious diseases or physical organic diseases; (5) Genital deformity, inflammation and tumor of the reproductive system are confirmed by examination; (6) having a genetic disease that is not suitable for reproduction as stipulated in the Law on Maternal and Child Health care; (7) Serious bad habits such as drug abuse; (8) Exposure to teratogenic radiation, poisons, and drugs at the active stage. Note: Any of the above 8 items shall be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Natural pregnancy rate;TCM syndrome integral;Basal sex hormone levels; | — |
Countries
China
Contacts
Public ContactZeng Qian
Affiliated Hospital of Chengdu University of TCM
Outcome results
None listed